我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
9
7 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
进行中（未招募）
7
77.8%
已完成
2
22.2%
暂无批准数据
- A revolutionary biodegradable heart valve scaffold developed by researchers at Harefield Hospital and Imperial College London shows promise in animal trials, potentially eliminating the need for repeated valve replacements. - Stem cell therapy for Parkinson's disease demonstrates encouraging safety data in the STEM-PD trial, with transplanted dopamine cells showing survival for 6-12 months post-transplantation. - Adverum Biotechnologies' single-dose gene therapy ixo-vec for wet AMD advances to Phase III trials, offering an alternative to monthly eye injections.
